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Health Research Board Members as at 31 December 2000
Chairman’s Statement
In 2000 the Health Research Board benefited from an unprecedented increase in the level of funding
made available from the Department of Health and Children to support its activities, for which the
Board is extremely grateful. Encouraged by the enhanced funding and ministerial commitment to health
research, the Board engaged in an extensive period of reflection and analysis. The Board published its
analysis of the challenge facing research related to human health in January, in the consultation
document, Making Knowledge Work for Health. Comments were invited on this document and a major
conference was held in Dublin Castle in March to stimulate debate and discussion on its contents. The
Board also commissioned the CIRCA Group to survey expenditure on health-related research in Ireland
in 1998 to establish a base figure and to calculate the relative expenditure across fields of health
research and by different agencies. The report confirmed the relatively low spend on health research,
illustrated the high proportion of spending on biosciences research and highlighted the absence in
many health agencies of systems to monitor research expenditure. 
In preparing its proposals for a strategy for health research for submission to the Department of Health
and Children, the Board incorporated the many comments and concerns that had been raised by people
and institutions with an interest in health and research. The Board is satisfied that the proposals made to
the Minister and the Department reflect a broad consensus of opinion as to how scientific knowledge
relevant to human health can be better supported and how research can assist in achieving the objectives
of the health services. As the year drew to a close, we awaited the publication of the Minister’s proposals
as to how the knowledge acquired through research could be better used for health.
Further analysis and reflection were stimulated by the Government’s most welcome announcement
that it proposed to implement the recommendations of the Technology Foresight Initiative by the
establishment of a new foundation, subsequently named Science Foundation Ireland, to fund world-
class research in biotechnology and information and communication technologies. The Board played
an active role in the implementation group established by the Department of Enterprise, Trade and
Employment to shape the new organisation and its method of operation. The Board was anxious to
ensure that the new Foundation would complement the long-standing work of the HRB in supporting
high-quality research in the biological sciences and building the skills of young researchers. It was keen
that the established links between the universities and the health services in supporting health-related
research should be strengthened. It was particularly concerned about the implications for the long-
term development of health-related research in this country of the possible establishment of research
institutes that would be independent of the third-level sector and the health services.
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The Board convened its own advisory group to develop the position of the human biosciences research
community on the implementation of the Technology Foresight Initiative. In particular, the advisory
group was asked to develop criteria for selecting the niche areas of biosciences research that are of
strategic importance to the development of biotechnology in this country and that should be reflected
in the operation of the Foundation. The report of the advisory committee emphasised that the links
that exist between bioscience researchers form one of the strengths of research in this country, and
that the involvement of patients, as a source of genetic and tissue material, is a key resource for
research and in formulating scientific questions for further research and facilitating the translation of
discoveries at the bench to the bedside. The existing close links between laboratory and clinical
scientists provide this country with a competitive advantage in research in the biosciences and in
biotechnology. The advisory group put forward criteria for selecting the niche areas of biosciences to
be funded and the Board was pleased that these criteria were met in those areas selected by the
Foundation in its first call. The Board was generally pleased with the arrangements agreed for the
operation of the new Foundation and, as the year closed, looked forward to working closely with it to
support high-quality research of benefit both to health and to our future economic development.
A common theme in the consultation document, Making Knowledge Work for Health, and in the report
of the advisory group, was the need to support people if research is to thrive. A priority for the Board is
the appointment of physician-scientists or medical consultants with a primary commitment to research
as joint appointments to our universities and hospitals. The Board met with a number of organisations
throughout the year to promote the idea of such appointments. Given the obvious need for such posts
and the good will of all parties, the Board is confident that progress can be made on this issue in the
near future.
The work of the HRB depends on the input of many people. May I thank all those who served on our
research committees, those who reviewed proposals, our research partners and those who agreed to
take part in our intra-mural research programmes, for their time and commitment. In particular, I
would like to thank those people who made submissions on our consultation document and
contributed to the development of thinking as to how best knowledge can work for health. The staff of
the Board have worked extraordinarily hard to assist the Board during this year of enhanced funding,
reflection and analysis. They have maximised the impact of the additional resources made available for
research, adapted with enthusiasm to technological changes, and maintained the highest standards of
research practice and research and information management. Finally, may I thank my fellow Board
members for their commitment and unfailing support.
________________________
Professor Michael B Murphy
Chairman of the Board
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Chief Executive’s Report
The Health Research Board (HRB) was most grateful to the Minister for Health and Children for the
substantial increase in its budget for 2000. The total funding available to the Board was £10.5 million for
the year, compared with £6.5 million in 1999. This additional income enabled the Board to expand greatly
its support for health-related research. 
The Board made a major contribution to policy on research in Ireland with the publication in January 2000
of a consultation document, Making Knowledge Work for Health – Towards a Strategy for Research and
Innovation for Health. Following a major conference in Dublin Castle in March 2000 and the receipt of over
one hundred comments, the Board put its proposals for a national research strategy for health to the
Department of Health and Children later in the year. The proposals envisage investment in two parallel but
complementary strands of research, one of which is called ‘Science for Health’, and the second ‘Research
and Development for Health’. The HRB envisages that it will continue to take the lead role in supporting
research under the heading of ‘science for health’ and it will assist the health services build an R & D
function for health. The staff of the Board are most grateful for the input of so many people to the
preparation of these proposals.
The Matching Funds Agreement between the HRB and the Wellcome Trust came to an end in September
2000. The Agreement, under which the Trust and the Health Research Board each made £3 million
available to support health-related research over a three-year period, was one of the most significant
initiatives to benefit health research in this country. Among the most important benefits was the
appointment of eight New Blood Fellows to universities and associated hospitals. These Fellowships
provided Irish researchers with tenure and the funding to make a major contribution to the development
of Irish bio-medical research. The New Blood Fellows presented their research at a most successful seminar
organised by the Wellcome Trust in London on 12 May 2000. The Board was pleased to assist the Trust
carry out an evaluation of the Agreement during the year. As Chief Executive, I would like to express my
thanks to the staff of the Trust, in particular Dr Andy Robertson and Dr Gavin Malloch, for their
commitment to the Agreement and for the co-operative spirit in which all issues were resolved.
As the year closed Mr Micheál Martin TD, Minister for Health and Children, had made arrangements to
meet Dr Michael Dexter, Director of the Wellcome Trust, and colleagues at the Irish embassy in London to
thank the Trust on behalf of the Irish Government for its participation in the Agreement.
During the year, the HRB, with assistance from the Wellcome Trust, was able to address long-standing
inadequacies in equipment needed for health-related research. A sum of over IR£2.8 million in research
equipment grants was made available on the basis of competitive peer review in two rounds of awards.
The HRB hopes that other deficiencies will be addressed in response to the survey of research equipment
and facilities in the Universities and the Royal College of Surgeons that is being undertaken by the PREST
consultancy group.
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The HRB took the opportunity at the end of 2000 to review and reorganise its project grant scheme so
that it would better reflect the science underlying research for health and support important areas of
research that were traditionally under-funded. Thirteen new research committees were established,
nominations were invited from the research community for membership of the committees and, in 2001,
interviews will be replaced by a greater emphasis on international peer review of all applications. It is also
hoped to increase significantly the amount of funding available for each award. 
The Board was pleased to co-fund research on arthritis with the Arthritis Foundation of Ireland. The Board
and the Foundation hope in this way to maximise the impact of their resources in combating this common
and disabling condition. 
The HRB has continued to build its links with the research community in Northern Ireland and the R & D
Office in Belfast in particular. The Cancer Consortium established under the 1999 Memorandum of
Understanding on Cancer, involving Ireland, Northern Ireland and the US National Cancer Institute (NCI),
has provided exciting opportunities to build capacity in cancer research on the island as a whole. The HRB
and the R & D Office awarded two Fellowships in Cancer Epidemiology, in association with the Cancer
Registries in Cork and Belfast. In September, a joint delegation from Ireland and Northern Ireland visited
the NCI in the United States to explore opportunities for enhanced co-operation in cancer research,
including clinical trials of new cancer therapies. As the year closed, the recommendation of the Consortium
that investment be made in hospitals to conduct cancer clinical trials was adopted by the Department of
Health and Children in Dublin and the Department of Health, Personal Social Services and Public Safety in
Belfast and the Board was making arrangements to issue a call for proposals. This funding will be the first
public investment in clinical trials in Ireland and will help ensure that patients receive state-of-the-art
treatment for cancer. The intention is to build clinical trial capacity on the island as a whole to enable
participation in trials sponsored by the NCI. The HRB and the R & D Office also agreed to sponsor
professionals working in cancer from Ireland and Northern Ireland to participate in the summer
programmes run by the NCI to deepen their knowledge and understanding of the disease, the insights of
recent research and the latest cancer therapies. It is hoped to offer this opportunity again in future years.
The intra-mural research activities of the Board continued to develop during the year. The Board published
the Annual Report of the National Intellectual Disability Database, 1998/1999. This database has proved
remarkably successful in providing the information needed to plan and fund services for people with an
intellectual disability. The Board also published reports on Treated Drug Misuse and the National Report on
Drug Issues in Ireland. The activities of the Drug Misuse Research Division were set to expand with the
decision of the Minister of State with responsibility for the National Drugs Strategy to support the Board in
developing a state-of-the-art library and dissemination centre on drug issues. The Division moved to new
premises to facilitate the development of this centre. Steady progress was reported in recruitment to the
genetic studies in which the Board is involved as a partner, namely, the Irish Affected Sib-Pair Study of
Alcohol Dependence, the Genetic Epidemiology of Schizophrenia, the Genetic Study of Neural Tube
Defects and the Genetic Study of Orofacial Clefts. 
During 2000 the Board established a Partnership Committee to provide a forum in which management
and staff can resolve issues of mutual concern. I would like to express my thanks to Isobel Butler, an
external consultant, for her skill in chairing the committee and for sharing her expertise in making
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partnership work. A new grading structure was also agreed for the organisation to reflect better the work
of the job families in the Board. I would like to express my thanks to Alpha Consulting for their advice and
to the staff for their hard work and commitment to designing the new grading structure. 
I would like to thank all the staff for their contribution to achieving the objectives of the Board during the year. 
________________________
Ruth Barrington
Chief Executive
10
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Medical and Health Services Research Division
The role of the Medical and Health Services Research Division is to fund health research, to evaluate
the effectiveness of the Health Research Board’s support for health research, to increase awareness of
research supported by the HRB and to further the strategic development of health research in the
context of national and international developments.
Achievements in 2000
There was an increase in 2000 in both the number and value of awards made to the health research
community. Expenditure on external research in 2000 was a record £7.8 million, an increase of £3.2
million on the previous year. A full list of awards made by the HRB in 2000 is included in the Appendix.
Awards of 72 project grants were made in the year. Among them were four awards made jointly with
the Arthritis Foundation of Ireland, and four all-island awards made jointly with the R & D Office of the
Northern Ireland Department of Health, Personal Social Services and Public Safety, as part of the
Ireland–Northern Ireland co-operation scheme.
As part of the HRB’s mission to support careers in health research, 20 fellowship awards were made.
These included eight clinical research training fellowships for medical doctors, three clinical research
fellowships in nursing and midwifery, four postdoctoral awards to research scientists and three awards
in the area of health services research. Two fellowships were awarded in cancer epidemiology as part of
the implementation of the Memorandum of Understanding on Cancer Research agreed between the
governments of Ireland, Northern Ireland and the United States in October 1999. These were awarded
jointly with the R & D Office in Northern Ireland and both Fellows will spend a year of their fellowship
at the National Cancer Institute in the USA.
An in-depth review of the HRB’s research committees was carried out. This involved extensive
consultation with the research community and resulted in significant changes to the organisation of
committees and their membership to reflect more effectively the scope of research supported by the
HRB. Also arising from the review, a new system of evaluation of grant applications was devised. These
changes will be implemented in 2001.
Inadequate funding for research equipment has been a long-standing problem for Irish researchers.
However, in 2000, health research infrastructure received a major boost with a £2.8 million investment
in capital equipment. Over 50 research teams benefited.
The Wellcome Trust / Health Research Board Matching Funds Agreement came to an end in 2000 and
an evaluation of its impact was carried out. The findings of the evaluation will be published in 2001. A
seminar was held at the Wellcome Trust in London for New Blood Fellows in May 2000, giving them
an opportunity to present their work in progress. 
This year’s Watt Medal was awarded to Kelebogile Motumise, a third-year medical student at Trinity
College Dublin, for his project entitled, The role of P glycoprotein expression and function in HIV disease.
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The 2000 Graves Lecture, sponsored by the Health Research Board and the Royal Irish Academy, was
given by Dr William Reardon from the National Centre for Medical Genetics, Our Lady’s Hospital for
Sick Children, Crumlin. Dr Reardon’s lecture was titled, Pendred syndrome – rare disorder or model for the
molecular age?
Staff changes in 2000
Kay Duggan-Walls joined the team as a Research Grants Officer with a background in the
pharmaceutical industry in clinical research.
Looking forward
A substantial increase in the budget for research support is anticipated in 2001. This will enable the
HRB to provide long-term support for teams of researchers working in areas relevant to health and
social gain.
A survey of research equipment and facilities in the universities and the Royal College of Surgeons
undertaken by the PREST consultancy group on behalf of the HRB and the Higher Education Authority
will be completed in 2001. It is hoped that the findings of this survey will help the HRB to target
infrastructure support in the most effective way.
The next phase in the Memorandum of Understanding on Cancer Research will be implemented with a
competitive call for the establishment of cancer clinical trial centres in hospitals.
In-house, the focus will be on the development of information systems within the Division: an eGrants
system will be piloted to allow electronic processing of grant applications and a new database of
research awards will be developed.
Staff of the Division
Mairéad O’Driscoll PhD, Head of Division
Patricia Butler MA
Judith Chavasse RGN MPhil
Patricia Cranley BA
Kay Duggan-Walls BSc HDip
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Child Health Epidemiology Division
Child Health Epidemiology Division
The Child Health Epidemiology Division of the Health Research Board is involved in epidemiological
research, mainly in the field of pregnancy and child health. The main focus of the current research
programme of the Division is on neural tube defects and other congenital malformations.
Achievements in 2000
Most of the work of the Division during 2000 continued to revolve around the US National Institute of
Child Health and Human Development (NICHD) contract research on neural tube defects (NTDs) and
orofacial clefts. Expansion of the research resulted in the appointment of a cleft research co-ordinator to
assist in a major drive to recruit people with orofacial clefts and their parents throughout Ireland.
Discussions were initiated with the Dublin Cleft Unit (an association of health professionals and institutions
treating people with clefts) to assess the feasibility of recruiting study subjects through cleft clinics at The
Children’s Hospital, Temple Street Hospital, Our Lady’s Hospital, Crumlin, and St James’s Hospital. The Cleft
Unit is very interested in and enthusiastic about the study and has been very accommodating.
The research team continued to liaise with branches of the Irish Association for Spina Bifida and
Hydrocephalus (IASBH) and the Northern Ireland Association for Spina Bifida and Hydrocephalus (ASBAH).
Recruitment of members from the branches took place through special meetings and home visits. Planning
for recruitment of members from ASBAH UK (England and Wales) was finalised and an application seeking
ethical approval was submitted to the UK-based Multi-Centre Research Ethics Committee (MREC). The
research team continued to liaise with public health nurses in the various community care areas
throughout Ireland with a view to recruiting families where a member has spina bifida. A document
requesting formal permission, and outlining what participation by public health nurses would involve, was
sent to several of the health boards and permission was obtained to proceed with the study.
The Division has been collaborating with the Department of Public Health Medicine and Epidemiology
in University College Dublin and the Departments of Diagnostic Imaging and Preventive Medicine in St
Vincent’s University Hospital, Dublin, in a case-control study of hip fracture in older Irish women. The
study has been completed. A research paper on risk factors for hip fracture and post-fracture mortality
has been submitted for publication and a second paper examining the outcome of hip fracture two
years after the event is in preparation.
Looking Forward
Continuing and extending the research on neural tube defects, the Division will co-ordinate
recruitment of subject families through liaison with the relevant associations in Ireland and Northern
Ireland and will initiate recruitment of families through the public health nurses. Once ethical approval
for the UK ASBAH study has been received, recruitment of ASBAH members from England and Wales
will commence. Analysis of data on a study of survival and handicap in a cohort of babies born with
spina bifida has been completed and the results will be written up in 2001.
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Continuing and extending the research on orofacial clefts, the Division will co-ordinate recruitment of
subject families through liaison with the Cleft Lip and Palate Association of Ireland and through the
cleft clinics at four Dublin hospitals.
Publications
Shields, D.C., Ramsbottom, D., Donoghue, C., Pinjon, E., Kirke, P.N., Molloy, A,M., Edwards, Y.H.,
Mills, J.L., Mynett-Johnson, L., Weir, D.G., Scott, J.M., Whitehead, A.S. (2000) Association between
historically high frequencies of neural tube defects and the human T homologue of mouse T
(Brachyury). American Journal of Medical Genetics, 92: 206-11.
Staff of the Division
Peadar Kirke MB FFPHMI FFPHM MSc DCH DObst, Head of Division
Helen Burke BSocSc
Miriam Lynch RGN MPsychSc
Ena Lynn RGN RM HDip
Mary Patricia McKeever PhD
Sharon Murray RGN RM
Marie Sutton MB BCh BAO MPH
Deborah Watson BSc
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Disability Databases Division
The Disability Databases Division of the Health Research Board is contracted to manage specific
national service-planning databases on behalf of the Disability Services Section in the Department of
Health and Children. Established in 1995, the National Intellectual Disability Database (NIDD) provides
a comprehensive information base for decision making in relation to the planning, funding, and
management of services for people with intellectual disability. The development of a similar database
for people with physical and sensory disabilities is currently being co-ordinated by this Division.
Achievements in 2000
National Intellectual Disability Database (NIDD)
The Division is responsible for the ongoing management and development of the National Intellectual
Disability Database. Early in 2000, a research analyst was recruited to fill a new post which had been
created in the Division.
The Annual Report of the National Intellectual Disability Database 1998/1999 was published. This
incorporated a summary of the 1998 data and included a mid-term review of the Department of
Health and Children’s document, Services to Persons with Mental Handicap/Intellectual Disability –
Assessment of Need 1997-2001, which was published in 1997.
Data collected from all the health boards during 2000 was imported and validated. The Division
continued to establish good-quality baseline data in each health board area for the purposes of
monitoring the implementation of the Department of Health and Children’s service development plan.
Following the National Clinical Evaluation of the National Intellectual Disability Database completed in
1999, the Division assisted in a Midland Health Board project to audit the quality of the data collected
as part of their regional dataset.
The Division managed the revision of the database software, which is currently under development. In
addition, it established the NIDD Software Management Group to undertake the strategic
management of the software which supports the national dataset.
In the course of the year, the National Intellectual Disability Database Committee approved the
inclusion of additional information on the database. The Information Manual for the NIDD, which
incorporates the protocols and guidelines, was revised to reflect these changes and circulated to all the
health boards. An updated national training programme for the NIDD was devised and administered
to health board personnel.
In addition to the various committees directly related to the NIDD, the Division represented the HRB
on the Legal Issues sub-Committee of the National Health Information Strategy Committee. This
committee examines issues of access to data, including the development of protocols for
confidentiality and release of data to third parties. The Division is also represented on the National
Monitoring Committee which was established by the Minister for Health and Children to oversee the
Government's investment programme in intellectual disability services.
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As part of the Division’s role in raising awareness of the National Intellectual Disability Database,
presentations were made at national and international conferences.
Overall, the availability of such detailed national data continued to be a key factor influencing the
Government’s decision to allocate additional funding (£83m in the 2000 Budget) for the development
of intellectual disability services. The database will continue to be used to monitor service developments
arising from this substantial investment.
National Physical and Sensory Disability Database
This Division co-ordinates the development of a National Physical and Sensory Disability Database. Progress
towards the establishment of this resource was made through the development of protocols and guidelines
for the new database. This included extensive consultation to establish the data content. The Division
designed and oversaw the first phase of implementation of the database in four community care areas
nation-wide. This first phase will act as a pilot for all aspects of the database before national implementation
to ensure that all proposals are capable of being implemented in a structured fashion. Part of the
implementation of Phase 1 involved the Division’s devising and implementing training programmes,
information manuals and interim software. Awareness of the database was raised through the dissemination
of information packs and leaflets, and the preparation of articles, website pages and presentations.
Looking Forward
National Intellectual Disability Database
The Division is preparing for the publication of two reports from the National Intellectual Disability
Database, those for 2000 and 2001. It will co-ordinate the work of the NIDD Software Management
Group and training in the new software. There will also be continued endeavours to ensure data quality.
It will implement a programme to improve regional use of the NIDD information by training database
administrators on data validation and report preparation and interpretation. It will continue to assist in
the work of the National Monitoring Committee.
National Physical and Sensory Disability Database
In the coming year, the Division will oversee the completion and evaluation of Phase 1 of the National Physical
and Sensory Disability Database. All aspects will be formally evaluated and the initial results analysed.
Subsequently, detailed proposals will be published and, on the recommendations of the Department of Health
and Children, the Division will co-ordinate the implementation of the database nationally. 
Publications
Mulvany, F. (2000) Annual Report of the National Intellectual Disability Database 1998/1999. Dublin: 
Health Research Board.
Staff of the Division
Fiona Mulvany BSocSc DipStats, Head of Division
Pamela Gallagher PhD DipStats
Damian O’Driscoll BA DipStats
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Drug Misuse Research Division
The Drug Misuse Research Division is a national centre for research on drug misuse issues in Ireland.
The research it carries out informs policy and contributes to academic understanding of drug misuse.
The Division maintains the National Drug Treatment Reporting System (NDTRS), which is the main
national epidemiological database on treated drug misuse in Ireland. The Division is the designated
Irish National Focal Point of REITOX (the European Information Network on Drugs and Drug Addiction)
which is co-ordinated by the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction).
As the National Focal Point, the Division co-operates with other centres across the EU to develop and
disseminate standardised drug-related information.
Achievements in 2000
Under its contractual obligations with the EMCDDA, the Division prepared a National Report on the
drug situation in Ireland and a second report entitled Joint Action on New Synthetic Drugs. During the
year the Division convened three national expert group meetings to further the development of key
indicators of drug misuse in Ireland with the aim of harmonising data collection across the EU. The
expert groups focused on: (1) prevalence of drug misuse, (2) drug-related infectious diseases, and (3)
drug-related deaths.
The Division was an active participant in the EMCDDA’s electronic database on Exchange on Drug
Demand Reduction Action (EDDRA). Projects in the EDDRA database are chosen to represent ‘best
practice’ in drug demand reduction activities in the EU Member States.
In May, staff of the Division briefed Mr Eoin Ryan TD, the Minister of State with special responsibility
for the National Drugs Strategy at the Department of Tourism, Sport and Recreation, on the Division’s
activities and on recent trends in drug misuse in Ireland and Europe. In July, the Division made a
submission to the Review Group of the National Drugs Strategy.
The Division continued to expand the coverage of the National Drug Treatment Reporting System
(NDTRS). Negotiation to include the NDTRS data from the prison services began. The Irish College of
General Practitioners agreed to include a training module on the use of the NDTRS for general
practitioners involved in prescribing methadone under the terms of the methadone protocol. One of
the Division staff, Tracy Kelleher, continued to train health professionals and providers of drug
treatment services in the concepts and requirements of the NDTRS. The Division published the NDTRS
Statistical Bulletin 1997 & 1998.
The second issue of the Division’s newsletter, Drugnet Ireland, was published in May 2000. Since its
launch in May 1999 by Professor Michael Murphy, Chairman of the HRB, feedback on Drugnet Ireland
from those interested in the drugs area in Ireland has been very positive. The newsletter fulfils a vital
role in information dissemination; its value is confirmed in this second informative issue, largely due to
the work of Paul Cahill of the Division.
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Staff from the Division were invited to make a presentation in December 2000 to the Drug Court
Committee on collecting epidemiological data on people who appear before the court.
In the course of the year the Division contributed input towards Masters Degree courses at both Trinity
College Dublin and University College Dublin.
Looking Forward
A number of research studies presently under way will be published in the coming year. Publications
planned include Drug Use Among Prisoners, An Overview of Drug Issues in Ireland 2000, A Collection
of Papers on Drug Issues in Ireland, a NDTRS report, and further issues of Drugnet Ireland.
Publications
Bryan, A., Moran, R., Farrell, E., O’Brien, M. (2000) Drug-Related Knowledge, Attitudes and Beliefs in
Ireland. Dublin: Health Research Board.
Dillon, L. (2000) Drug use by prisoners: a review of the Irish situation. In Drug Use in Prison, ed. R.
Muscat. Strasbourg: Council of Europe Publishing, 53-64.
Drug Misuse Research Division. (2000) Drugnet Ireland, ed. P. Cahill. Dublin: Health Research Board.
O’Brien, A., Moran, R., O’Brien, M. (2000) Annotated Bibliography of Drug Misuse in Ireland. Dublin:
Health Research Board.
O’Brien, M., Moran, R., Kelleher, T., Cahill, P. (2000) National Drug Treatment Reporting System:
Statistical Bulletin 1997 & 1998. Dublin: Health Research Board.
Smyth, B., O’Brien, M., Barry, J. (2000) Trends in treated opiate misuse in Dublin: the emergence of
chasing the dragon. Addiction, 95: 1217-1223.
Staff of the Division
Ros Moran MA MSc HDE, Head of Division
Paul Cahill BA MPsychSc
Lucy Dillon BA
Mary Dunne RGN BSc DipH&SocWelfare
Eimear Farrell BA MSc
Tracy Kelleher BA HDip
Mary O’Brien BA DipStats HDipSoc&SocRes
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Mental Health Research Division
The Mental Health Research Division compiles and analyses national epidemiological information on
mental illness in Ireland. The Division houses the National Psychiatric In-patient Reporting System
(NPIRS) and the Westmeath and Roscommon Case Register databases. Both databases are invaluable
sources of information for planning and research in the mental health area in Ireland. Staff of the
Division are involved in research projects on the genetics of schizophrenia and alcohol; service
availability, need and usage in the mental health area; depression and suicide.
The Division encourages the use of the NPIRS and Psychiatric Case Register databases for research
purposes and disseminates research findings.
Achievements in 2000
The NPIRS epidemiological database provides detailed information regarding admissions and
discharges to in-patient psychiatric services and is an invaluable resource for planners, researchers and
clinicians. During the year the annual report analysing information from this database, Activities of Irish
Psychiatric Services 1999, was published. Data on the availability and usage of community psychiatric
services were included in this document.
First admission rates have changed little over the last 35 years, however, first and repeat admissions
taken together show a near doubling of admissions over this period. The differences between socio-
economic groups persist, with the poorer sectors of society having a much higher admission rate than
those more socio-economically favoured. The non-voluntary admission rate remains high compared
with international figures. In 1999, 11% of admissions were non-voluntary. 
The Division continued to assist hospitals in converting to a system of computerised returns of
information. Further research studies based on the NPIRS database are under way.
The Westmeath and Roscommon Psychiatric Case Register gathers information regarding the users and
usage of community and in-patient psychiatric services for defined geographical areas. The data are
longitudinal and person-linked but anonymous, and are invaluable for clinical and service management
purposes. Several research studies based on this database are under way. Progress was made in getting
the database up-to-date; this effort will be continued.
The Irish Affected Sib-Pair Study of Alcohol Dependence attempts to identify the specific loci of the
genes that may be involved in the development of alcohol dependence. This international project,
which, commenced in late 1997, is undertaken as a collaboration between the Health Research Board
and the Medical College of Virginia and is funded by the National Institute of Alcohol Abuse and
Alcoholism. Genetic material from sibling pairs, where both have a history of alcohol dependence, is
analysed. Recruitment of study participants will continue during the year 2001.
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Another major study, The Genetic Epidemiology of Schizophrenia in Ireland, is funded by the US
National Institute of Mental Health and is a collaborative project between the Health Research Board,
Queen’s University Belfast and the Medical College of Virginia. The study seeks to identify genes that
predispose to schizophrenia. Fieldwork for this study began in October 1999 and continued
throughout the year 2000 with the recruitment of family members affected by schizophrenia. In the
course of the year, ethical approval was obtained from relevant ethics committees and contact was
made with Schizophrenia Ireland to publicise the research and to encourage families to participate in
the study. Specialised, intensive training in interviewing techniques was provided to new researchers
on the project. A detailed database was designed for recording details of participants in the study.
The Day Hospital Study is concerned with the utilization of day hospitals and day centres from the
perspective of service managers, clinicians and consumers. The study aims to identify the extent and
appropriateness of current provision and explore the views of mental health specialists and other users.
The results will provide useful indicators as to how the existing provision may be strengthened and
revised if this appears appropriate. In addition, results can inform formal standards and guidelines for
partial hospitalisation in Ireland leading to a greater standardisation of care. Fieldwork for the study
commenced during 2000.
Projects are underway on service availability, need, and usage in the mental health area; schizophrenia,
depression and suicide. A number of these studies use the in-house databases to answer important
research questions.
Looking Forward 
The following developments are planned: coverage and quality of data in the NPIRS and Case Register
databases will be reviewed; the Division will continue to assist hospitals in converting to
computerised/electronic data returns; recruitment of participants to the Schizophrenia and Alcohol
studies will continue and a control group (of approximately 400 individuals) will be recruited.
Further publications based on the work carried out in the Division are planned, including Activities of Irish
Psychiatric Services 2000, and results from the Irish Psychiatric In-Patient and Hostel Census, 31 March
2001. In addition, research papers based on the NPIRS and Case Register databases are also planned.
The changes in health board catchment areas due to the establishment of the Eastern Regional Health
Authority will involve liaison with the ERHA and the Central Statistics Office to establish new
population bases for the various health board areas in the ERHA.
It is planned to put the management and other infrastructure in place to facilitate staff who wish to avail
of teleworking arrangements and to recruit new staff in order to achieve the targets outlined above.
The Division will continue to provide training and opportunities for social researchers to work to
increase knowledge and understanding related to mental health in Irish society.
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Finance and Administration Division
The role of the Finance and Administration Division is to support the Board and the Chief Executive in
the implementation of the Board’s policies and decisions, and to facilitate the work of the Board’s staff.
Staffing and Personnel
At the end of 2000 the HRB had 45 members of staff, including many highly qualified and experienced
scientific and social researchers engaged directly in research and administration. Recruitment during
the year was focused on augmenting existing divisional teams and staff replacement.
In October Dr Conor O’Callaghan retired after 41 years’ service with the HRB and its predecessor
organisation, the Medical Research Council of Ireland. Dr O’Callaghan had been based at Trinity
College Dublin and his most recent area of research was the design and development of new inhibitors
of protein tyrosine kinases. We would like to take this opportunity to thank Dr O’Callaghan for his
excellent contribution to health research throughout his long career.
The introduction of an active Partnership Committee at the beginning of 2000 provided an ideal
forum for the development of an employee handbook that met the needs of all staff. The year also saw
the introduction of a job-grading structure that reflects the special nature of the HRB’s activities.
The implementation of the HRB’s policies on family friendliness and work-life balance was evidenced
during the year with the introduction of a pilot teleworking project and four staff members availing of
the parental leave scheme. The HRB is committed to attracting and retaining the best staff, and to
providing them with the means to realise their full potential. It encourages staff to avail of third-level,
postgraduate, or equivalent courses considered to be of value to them in their work and in their own
personal development. All staff took part in training courses during the year.
Finance
The total income of the Health Research Board for 2000 was IR£10,526,728 (1999: IR£6,403,181). This
was made up of revenue income of IR£7,802,728 (1999: IR£5,776,181) and capital income of
IR£2,724,000 (1999: IR£627,000). Total revenue expenditure on research grants and fellowships
increased by 27% in 2000, to £5,111,543. This includes research equipment funding of IR£58,334
made available out of revenue income. Capital expenditure on grants for research equipment increased
to IR£2,724,000 (1999: IR£522,000).
Increased income from external research funding, and increased expenditure in the intramural research
divisions, reflect the first full year of operation with complete staff complements and recently signed
research contracts from the National Institute of Child Health and Human Development (USA), and
Virginia Commonwealth University (USA).
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The result for the year was a surplus of IR£24,006 and the Board’s accumulated revenue reserves at the
end of 2000 amounted to IR£62,158.
Once again, the assistance of the finance offices of the recipient research institutions in the
administration of the HRB’s award schemes is gratefully appreciated.
Fig. 1 HRB Total Expenditure 1995-2000
Buildings, Facilities, and Information Technology
In February the Health Research Board signed a lease on additional office accommodation at 19
Clanwilliam Terrace, Dublin 2, and when fitting out was completed this building was used to
accommodate the staff of the Drug Misuse Research Division. Information and communication
technology systems were upgraded to provide multi-site functionality.
The continuous improvement of the HRB website has greatly facilitated communication between the
Board, the research community and the general public.
The Partnership Committee again provided excellent ideas and advice on the development of all of the
HRB’s facilities.
Looking Forward
In 2001 the Finance and Administration Division will look to streamline the payment of the General
Research Project Grants Scheme with the objective of establishing procedures that will facilitate the
collection of information on research funding by the research institutions. This is part of an ongoing
process that will also develop enhanced payment procedures to enable the Board to increase its research
funding activities without incurring a proportional increase in the associated administration costs.
By the end of 2001 it is hoped that a new grants database will be operational that will facilitate the
increased activity.
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The production of comprehensive human resource policies will proceed during 2001 and will make a
significant contribution in effecting many changes throughout the organisation and enhance the
services provided. The development of an Intranet will provide a facility for internal communication for
the Health Research Board’s staff.
Staff of the Division
Carol Cronin BComm FCA, Secretary to the Board, Head of the Division
Ashling Dwyer
David Flood
Leo Johnson
Sarah Lynch
Karen O’Donnell BSc
Yvonne Russell
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Statement of Board Members’ Responsibilities
The Board is required by the Health Research Board (Establishment) Order 1986 to prepare Financial
Statements for each financial year which give a true and fair view of the state of affairs of the Health
Research Board and of its income and expenditure for that period. In preparing those Financial
Statements the Board is required to:
- select suitable accounting policies and apply them consistently
- make judgements and estimates that are reasonable and prudent
- state whether applicable accounting standards have been followed, subject to any material
departures disclosed and explained in the financial statements
- prepare the Financial Statements on the going concern basis unless it is inappropriate to presume
that the Health Research Board will continue in operation.
The Board is responsible for keeping proper books of accounts which disclose with reasonable accuracy
at any time the financial position of the Health Research Board and enable it to ensure that the
Financial Statements comply with the Order. It is also responsible for safeguarding the assets of the
Health Research Board and hence for taking reasonable steps for the prevention and detection of fraud
and other irregularities.
On behalf of the Board:
Professor Michael B Murphy Edward Rowland
Chairman Board Member
17 October 2001
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Report of the Comptroller and Auditor General
I have audited the financial statements on pages 38 to 49.
Responsibilities of the Board and of the Comptroller and 
Auditor General
The accounting responsibilities of the members of the Board are set out in the Statement of Board Members'
Responsibilities on page 36. It is my responsibility under Section 5 of the Comptroller and Auditor General
(Amendment) Act 1993 to audit the financial statements presented to me by the Board and to report on
them. As the result of my audit I form an independent opinion on the financial statements.
Basis of Opinion
In the exercise of my function as Comptroller and Auditor General I plan and perform my audit in a
way which takes account of the special considerations in relation to management and operations
which attach to bodies in receipt of substantial funding from the State.
An audit includes examination, on a test basis, of evidence relevant to the amounts and disclosures in
the financial statements. It also includes an assessment of the significant estimates and judgements
made in the preparation of the financial statements and of whether the accounting policies are
appropriate, consistently applied and adequately disclosed.
My audit was conducted in accordance with auditing standards which embrace the standards issued
by the Auditing Practices Board and in order to provide sufficient evidence to give reasonable
assurance that the financial statements are free from material misstatement whether caused by fraud or
other irregularity or error. I obtained all the information and explanations that I required to enable me
to fulfil my function as Comptroller and Auditor General and, in forming my opinion, I also evaluated
the overall adequacy of the presentation of information in the financial statements.
Opinion
In my opinion, proper books of account have been kept by the Board and the financial statements,
which are in agreement with them, give a true and fair view of the state of affairs of the Board at 31
December 2000 and of its income and expenditure and cash flow for the year then ended.
John Purcell
Comptroller and Auditor General
5 November 2001
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Statement of Accounting Policies
The financial statements are prepared under the historical cost convention and in accordance with
generally accepted accounting principles.
Income Recognition
The Department of Health and Children’s revenue grant is credited to the income and expenditure
account in full in the year it is allocated. Capital grants are accounted for on an accruals basis. All other
research funding is recognised as income when it is used to offset matching expenditure. Such funding
includes a contribution towards the administration costs of the Board.
Expenditure Recognition
Funding for research awards is recognised as expenditure in the period in which it is scheduled for
payment to the award holder. All other expenditure is recognised on an accruals basis.
Tangible Fixed Assets
Tangible fixed assets are stated at cost less accumulated depreciation. The charge for depreciation is
calculated to write down the cost of the tangible fixed assets to their estimated residual values, by
annual installments, over their expected useful lives on the following basis:
Premises 4%
Office Furniture and Equipment 15%
Computer Equipment 25%
Tangible fixed assets costing less than IR£500 are not capitalised.
Debtors
Known bad debts are written off and specific provision is made for any amounts the collection of
which is considered doubtful.
Pensions
One employee of the Board is a member of a fully funded defined benefit pension scheme, which is
funded by contributions from the Board. The fund is vested in independent trustees nominated by the
Board, for the sole benefit of the employee and her dependants. The adequacy of the fund to meet
pension liabilities is periodically assessed by an independent qualified actuary. The most recent
actuarial valuation, which was carried out on 1 May 1996, showed the scheme to be in surplus and for
this reason the Board is not currently making contributions to the fund.
All other permanent staff are members of the Local Government Superannuation Scheme. Pensions
arising under this scheme are paid out of current funds as they arise, and pension contributions
deducted from staff are netted against pension payments as shown in note 5. No provision has been
made in the accounts in respect of accrued superannuation benefits payable in future years.
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Revenue Income and Expenditure Account
for the year ended 31 December 2000
Notes 2000 2000 1999
€ IR£ IR£
INCOME
Department of Health and Children Revenue Grant 6,386,783 5,030,000 4,256,114 
Other Research Funding 1 1,553,994 1,223,869 726,359 
Projects Undertaken for
the Department of Health and Children 2 1,943,096 1,530,313 784,255 
Interest Receivable 21,738 17,120 5,290 
Other Income 1,810 1,426 4,163 
9,907,421 7,802,728 5,776,181 
Less:  Transfer to Capital Fund of Amount Allocated
to Fund Fixed Assets (73,167) (57,624) (65,416)
9,834,254 7,745,104 5,710,765
EXPENDITURE
Research Grants and Fellowships 3 6,490,321 5,111,543 4,031,022 
Child Health Epidemiology Division 744,437 586,292 348,890 
Drug Misuse Research Division 391,648 308,447 244,067 
Mental Heath Research Division 757,437 596,529 352,978 
Disability Databases Division 166,905 131,448 50,443 
Administration Costs and General Overheads 4 1,040,956 819,821 585,034 
Pensions Paid to Retired Members of Staff 5 53,401 42,057 52,835 
Research Staff at Trinity College Dublin 6 45,700 35,992 43,740 
Other Activities 112,968 88,969 69,921 
9,803,773 7,721,098 5,778,930 
SURPLUS/(DEFICIT) FOR THE YEAR 30,481 24,006 (68,165)
All income and expenditure for the year ended 31 December 2000 relates to continuing activities.
The Board has no recognised gains or losses other than those dealt with in the revenue and capital
statements of income and expenditure.
The Statement of Accounting Policies and notes 1 to 16 form part of these Financial Statements.
Professor Michael B Murphy Edward Rowland
Chairman Board Member
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Capital Income and Expenditure Account
for the year ended 31 December 2000
2000 2000 1999
€ IR£ IR£
INCOME
Department of Health and Children Capital Grant 3,458,767 724,000 627,000 
Amortisation of Capital Fund Account 90,256 71,083 63,951 
3,549,023 2,795,083 690,951 
EXPENDITURE
Equipment Grants Paid to Third Parties 3,458,767 2,724,000 522,000 
Repairs and Renewals - - 78,271 
Consultancy - - 8,203 
Contribution to Fixed Assets - - 18,526 
Depreciation 90,256 71,083 63,951 
3,549,023 2,795,083 690,951 
SURPLUS/(DEFICIT) FOR THE YEAR - - -   
The Statement of Accounting Policies and notes 1 to 16 form part of these Financial Statements.
Professor Michael B Murphy Edward Rowland
Chairman Board Member
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Balance Sheet
as at 31 December 2000
Notes 2000 2000 1999
€ IR£ IR£
FIXED ASSETS
Tangible Assets 7 420,917 331,499 344,958 
CURRENT ASSETS
Debtors 8 832,251 655,451 339,329 
Investments 9 425,843 335,379 322,156 
Cash at Bank and on Hand 1,601,862 1,261,569 600,041 
2,859,956 2,252,399 1,261,526 
CURRENT LIABILITIES
Amounts falling due within one year:
Bank and Other Advances 10 250,237 197,078 - 
Creditors and Deferred Income 11 2,530,795 1,993,163 1,223,374 
2,781,032 2,190,241 1,223,374 
NET CURRENT ASSETS 78,924 62,158 38,152 
NET ASSETS 499,841 393,657 383,110 
RESERVES
Accumulated Surplus on
Income and Expenditure Account 12 78,924 62,158 38,152 
Capital Fund 13 420,917 331,499 344,958 
499,841 393,657 383,110
The Statement of Accounting Policies and notes 1 to 16 form part of these Financial Statements.
Professor Michael B Murphy Edward Rowland
Chairman Board Member
41
Health Research Board
Cash Flow Statement
for the year ended 31 December 2000
Notes 2000 2000 1999
€ IR£ IR£
Reconciliation of Operating Surplus to
Net Cash Inflow from Operating Activities
Surplus/(Deficit) for the Year 30,481 24,006 (68,165)
Less Interest Receivable (21,738) (17,120) (5,290)
(Increase) in Debtors (401,391) (316,122) (27,456)
Increase in Creditors and Deferred Income 977,430 769,789 494,056 
Net Cash Inflow from Operating Activities 581,782 460,553 393,145 
Net Cash Inflow from Returns on Investments and
Servicing of Finance 21,738 17,120 5,290 
Amount Allocated to Fund Fixed Asset Additions (73,167) (57,624) (83,942)
Net Cash Inflow Before Investing Activities 533,353 420,049 314,493 
Investing Activities
Expenditure on Fixed Assets 73,167 57,624 83,942 
Increase in Cash and Cash Equivalents 14 606,520 477,673 398,435 
The Statement of Accounting Policies and notes 1 to 16 form part of these Financial Statements.
Professor Michael B Murphy Edward Rowland
Chairman Board Member
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Notes to the Financial Statements
for the year ended 31 December 2000
1. OTHER RESEARCH FUNDING
2000 2000 1999
€ € IR£ IR£ IR£ IR£
Research Grants and Fellowships
Irish Heart Foundation 33,331 26,250 35,000 
Arthritis Foundation 38,092 30,000 -   
Dept. of Social Community and Family Affairs 16,650 13,113 -   
VHI -   - 15,000 
88,073 69,363 50,000 
Child Health Epidemiology Division
National Institute of Child Health
and Human Development (USA) 683,557 538,345 306,167 
683,557 538,345 306,167 
Drug Misuse Research Division
Dept. of Justice Equality and Law Reform 8,434 6,642 12,048 
European Monitoring Centre for 
Drugs and Drug Addiction 100,000 78,756 69,191 
108,434 85,398 81,239
Mental Health Research Division
Eastern Regional Health Authority 113,653 89,509 85,334 
Virginia Commonwealth University 560,277 441,254 203,619 
673,930 530,763 288,953 
1,553,994 1,223,869 726,359
2. PROJECTS UNDERTAKEN 
FOR THE DEPARTMENT OF 2000 2000 1999
HEALTH AND CHILDREN € € IR£ IR£ IR£ IR£
Research Grants and Fellowships
Hepatitis C Research 295,114 232,421 272,707 
Nursing Homes Research 19,364 15,250 -
Nursing and Midwifery Research 330,368 260,186 71,211 
Health Status Research 76,184 60,000 60,000 
North–South Research Schemes 457,257 360,119 -   
Cancer Research 152,368 120,000 80,000 
1,330,655 1,047,976 483,918 
Drug Misuse Research Division 296,165 233,249 173,042 
Mental Health Research Division 31,235 24,600 6,931 
Disability Databases Division 172,074 135,519 50,443
Other Activities
Wellcome Trust  VAT Refund Scheme 112,967 88,969 69,921 
1,943,096 1,530,313 784,255
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3. RESEARCH GRANTS AND FELLOWSHIPS
2000 2000 1999
€ IR£ IR£
General Research Project Grants 2,724,813 2,145,965 1,561,357 
Research Units 695,702 547,910 737,250 
Equipment Grants 74,069 58,334 -   
North/South Co-operative Research Grants 457,257 360,119 212,420 
Discipline Integration Grants 105,726 83,266 51,696 
Post Graduate Training Grants 381 300 -   
Co-operative Health Services Research Grants 69,836 55,000 62,950 
Research Visits Scheme 13,396 10,550 6,346 
Summer Student Grants 38,396 30,239 26,671 
Science Degree Scholarships 45,046 35,477 47,334 
Conference Grants -   - 3,000 
Post Doctoral Research Fellowships 541,503 426,468 281,550 
Clinical Research Training Fellowships 504,304 397,172 380,423 
Health Services Research Fellowships 406,010 319,759 236,107 
Nursing Homes Research 19,364 15,250 -   
Nursing and Midwifery Research Fellowships 330,368 260,186 71,211 
Hepatitis C Research 295,114 232,421 272,707 
Study of National Cohort of Children 16,664 13,124 -   
Cancer Research 152,372 120,003 80,000 
6,490,321 5,111,543 4,031,022 
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4. ADMINISTRATION COSTS AND GENERAL OVERHEADS
2000 2000 1999
€ IR£ IR£
Salaries and Pensions 394,117 310,393 269,248 
Travel, Subsistence and Training 95,794 75,444 40,080 
Insurance 23,026 18,135 15,374 
Printing and Stationery 28,523 22,464 5,614 
Postage 9,029 7,111 6,620 
Telephone 18,505 14,574 7,290 
Light and Heat 3,719 2,929 2,203 
Repairs and Maintenance 84,289 66,383 5,641 
Cleaning 6,317 4,975 4,471 
Subscriptions to International Organisations 22,417 17,655 18,158 
Books, Journals and Subscriptions 6,846 5,392 2,830 
Bank Interest and Charges 2,525 1,988 1,458 
Annual Reports and Newsletters 1,231 970 9,863 
Computer Costs 63,611 50,097 56,969 
Website 8,467 6,668 3,771 
Consultancy 59,212 46,633 78,740 
Audit Fees 4,190 3,300 2,970 
Advertising 89,153 70,214 41,443 
HRB/Wellcome Trust Agreement Costs -   - 12,291 
Strategy Costs 60,339 47,521 -   
Partnership 7,269 5,725 -   
Office Rental 52,377 41,250 -   
1,040,956 819,821 585,034
5. PENSIONS PAID TO RETIRED MEMBERS OF STAFF
2000 2000 1999
€ IR£ IR£
Pension Payments 112,931 88,940 81,253 
Less: Contributions from Current Staff (59,530) (46,883) (28,418)
53,401 42,057 52,835
6. RESEARCH STAFF AT TRINITY COLLEGE, DUBLIN 
The permanent member of the Health Research Board's staff based at Trinity College, Dublin, researching
the design and development of new inhibitors of protein tyrosine kinases, retired on 6 October 2000.
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7. FIXED ASSETS - TANGIBLE ASSETS
Office
Furniture &
Premises Equipment Computers Total Total
IR£ IR£ IR£ IR£ €
Cost
At beginning of year 303,041 117,250 132,229 552,520 701,556 
Additions -   36,439 21,185 57,624 73,167 
Disposals -   -   -   -   
At end of year 303,041 153,689 153,414 610,144 774,723 
Depreciation
At beginning of year 99,057 53,024 55,481 207,562 263,550 
Charge for year 12,121 22,528 36,434 71,083 90,256 
Disposals -   -   -   -   -   
At end of year 111,178 75,552 91,915 278,645 353,806 
Net Book Value
at 31 December 2000 191,863 78,137 61,499 331,499 420,917
At 31 December 1999 203,984 64,226 76,748 344,958 
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8. DEBTORS 2000 2000 1999
€ IR£ IR£
Department of Health and Children 63,356 49,897 27,510 
Other Debtors 524,272 412,898 267,063 
Prepayments and Sundry Receivables 244,623 192,656 44,756 
832,251 655,451 339,329
9. INVESTMENTS 2000 2000 1999
€ IR£ IR£
At Cost At Cost At Cost
ACC Bank PLC Commercial Paper 425,202 334,874 321,651 
Prize Bonds 641 505 505 
425,843 335,379 322,156
10. BANK AND OTHER ADVANCES
Amounts falling due within one year: 2000 2000 1999
€ IR£ IR£
Bank overdraft 250,237 197,078 -   
11. CREDITORS AND DEFERRED INCOME
Amounts falling due within one year: 2000 2000 1999
€ IR£ IR£
Creditors and Accruals 1,375,044 1,082,935 692,910 
Deferred Income 1,155,751 910,228 530,464 
2,530,795 1,993,163 1,223,374
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12. ACCUMULATED SURPLUS ON
INCOME AND EXPENDITURE ACCOUNT
2000 2000 1999
€ IR£ IR£
At the beginning of the year 48,443 38,152 106,317 
Surplus/(deficit) for the year 30,481 24,006 (68,165)
Retained Surplus 78,924 62,158 38,152
13. CAPITAL FUND
2000 2000 1999
€ IR£ IR£
At the beginning of the year 438,006 344,958 324,967 
Transfer from Revenue Income and Expenditure Account
to fund Fixed Assets 73,167 57,624 65,416 
Transfer from Capital Income and Expenditure Account
to fund Fixed Assets -   18,526 
Depreciation charge for the year (90,256) (71,083) (63,951)
At the end of the year 420,917 331,499 344,958
14. ANALYSIS OF CASH AND
CASH EQUIVALENTS
Change in Change in
Year Year 2000 1999
€ IR£ IR£ IR£
Investments 16,790 13,223 335,379 322,156 
Cash at Bank and on Hand 839,967 661,528 1,261,569 600,041 
Bank Overdraft (250,237) (197,078) (197,078) -   
606,520 477,673 1,399,870 922,197
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15. BOARD MEMBERS' INTERESTS
Grants are, from time to time, made to bodies with which members are connected whether through
employment or otherwise.  The Board has instituted a confidential scoring system for decision making
purposes which also ensures that no one member can exercise undue influence over grant allocations.
16. BOARD APPROVAL
The Financial Statements were approved by the Board on 17 October 2001.
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Statement re Prompt Payments of 
Accounts Act 1997
Year ended 31 December 2000
Under Ministerial Order of June 1997 the Prompt Payment of Accounts Act came into operation on 2
January 1998. The Health Research Board comes under the remit of the Act. The following is the report
on the payment practices of the Board for the year ended 31 December 2000 in accordance with the
requirements as out in Schedule 12 of the Act.
It is the policy of the Health Research Board to ensure that all invoices are paid promptly. Specific
procedures are in place to ensure that any late payments are identified and any arising interest is paid.
The controls are designed to provide reasonable, and not absolute, assurance against non-compliance
with the Act.
There were no late payments during 2000 and accordingly no interest was paid in the year.
Carol Cronin
Secretary
17 October 2001
Health Research Board
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Prompt Payment of Accounts Act 1997
Report of the Comptroller and auditor General pursuant to
Section 13 of the Prompt Payment of Accounts Act 1997
Responsibilities of the Board and of the Comptroller and 
Auditor General
The Board is obliged to comply with the Act and, in particular, is required to
• pay its suppliers within the payment periods specified in the Act;
• If payment to a supplier is late, include the appropriate penalty interest with the payment together
with the information required by Section 6;
• Disclose the Board's payment practices in the period on the appropriate way.
Under Section 13 of the Act, it is my responsibility, as Auditor of the Board, to report on whether, in all
material respects, the Board has complied with the provisions of the Act.
Basis of Opinion
My examination included a review of the payment systems and procedures in place and checking, on
a test basis, evidence relating to the operation of the Act by the Board during the year.
I obtained all the information and explanations which I considered necessary for the exercise of my
function under Section 13 of the Act.
Opinion
As a result of my examination, it is my opinion that the Board complied in all material respects with
the provisions of the Act during the year ended 31 December 2000.
John Purcell
Comptroller and Auditor General
5 November 2001
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Dublin 2
Solicitors Arthur Cox
Earlsfort Centre
Earlsfort Terrace
Dublin 2
Auditors Comptroller and Auditor General
Dublin Castle
Dublin 2
52
Health Research Board
Appendix
53
Research Grants and Fellowships
Awarded in 2000
1. General Research Project Grants
Cardiovascular Diseases Committee
Grant Holder Institution Project
Dr Niamh Moran Department of Clinical Pharmacology Analysis of the integrin proteome
Royal College of Surgeons in the human platelet: towards an
in Ireland understanding of the integrin
Dublin 2 switch in arterial thrombosis
Dr Paul Cahill School of Biotechnology Mechanical force-induced
Dublin City University vascular smooth muscle cell
Glasnevin apoptosis
Dublin 9
Professor Des Fitzgerald Department of Clinical Pharmacology Regulation of cardiomyocyte cell 
Royal College of Surgeons death by eicosanoids: potential for 
in Ireland limiting cardiac toxicity of
Dublin 2 chemotherapy
Dr Alan Keenan Department of Pharmacology Role of nitric oxide synthases in 
Conway Institute of Biomolecular type II diabetes-induced vascular
& Biomedical Research dysfunction
University College Dublin
Belfield 
Dublin 4
Dental Sciences Committee
Grant Holder Institution Project
Professor David Coleman et al. Department of Oral Surgery, Oral An investigation of bacterial 
Medicine & Oral Pathology contamination of dental chair
School of Dental Sciences units, dental unit water and
Trinity College water lines with Pseudomonas 
Dublin 2 species and Burkholderia 
(Pseudomonas) cepacia
Dr Niall McGuinness Department of Orthodontics Predicting the outcome of 
Merlin Park Hospital treatment in Angle’s Class III
Galway division 1 malocclusion treated
in the permanent dentition using
fixed appliances
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Professor Brian O’Connell Department of Restorative In vivo function and regulation of 
Dentistry & Periodontology salivary antimicrobial proteins
School of Dental Science
Trinity College 
Dublin 2
Gastroenterology Committee
Grant Holder Institution Project
Mr Eamon Kavanagh/ Department of Surgery Characterisation of a heat
Professor Redmond Cork University Hospital shock protein-reactive regulatory
University College Cork T-cell population in inflammatory
Wilton bowel disease
Cork
Dr Aiden McCormick/ Liver Unit The role of nitric oxide synthase in  
Dr Docherty St Vincent’s University Hospital the development of the portal-
Elm Park systemic collateral circulation in
Dublin 4 portal hypertension
Dr Ross McManus Department of Clinical Medicine Investigation of inherited genetic
Trinity Faculty of Health Sciences factors influencing expression of 
St James’s Hospital the multiple drug resistance gene
James’s Street (MDR1)
Dublin 8
Professor Dermot Kelleher/ Department of Clinical Medicine Investigation of the functional
Dr Ryan Trinity Faculty of Health Sciences significance of a polymorphism in 
St James’s Hospital p53 homologue: Its role in
James’s Street oesophageal neoplasia
Dublin 8
Dr Joe O’Connell et al. Department of Medicine The p53 pathway in colonocyte 
University College Cork apoptosis during IBD
Wilton
Cork
Professor Colm O’Morain/ Adelaide & Meath Hospital Tumour Necrosis Factor (TNF) 
Dr Ryan Incorporating the National Children’s promoter region polymorphisms
Hospital/TCD in Helicobacter Pylori infection:
Tallaght influences on susceptibility to 
Dublin 24 infection and development of 
disease
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Genetics Committee
Grant Holder Institution Project
Dr Louise Gallagher/ Department of Psychiatry The genetics of autism: Linkage
Dr Gill Trinity Centre for Health Sciences disequilibrium screen in the Irish
St James’s Hospital population
James’s Street
Dublin 8
Dr Patrick McKeon/ Department of Psychiatry Towards identifying susceptibility 
Dr Mynett-Johnson TCD/St Patrick’s Hospital loci for bipolar disorder - following
James’s Street up a genome screen
Dublin 8
Health Services Research Committee
Grant Holder Institution Project
Dr Catherine Comiskey Department of Mathematics An analysis of the impact and cost
National University of Ireland of Hepatitis C Virus (HCV) 
Maynooth infection in Irish drug users
Co Kildare
Dr Marie Reilly National Cancer Registry Consistence, appropriateness and
University College Cork management of cancer services
Wilton in Ireland
Cork
Dr Martine Smith School of Clinical Speech & Enhancing communication for 
Language Studies adults with severe speech and
Trinity College physical impairment
Dublin 2
Immunology and Pathology Committee
Grant Holder Institution Project
Professor Kingston Mills Infection & Immunity Group Modulation of immune response
Department of Biology by filamenetous haemaglutinin 
National University of Ireland from Bordetella Pertussis
Maynooth
Co Kildare
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Professor Thomas Cotter Department of Biochemistry Apoptosis in retinitis pigmentosa
University College Cork associated with retinal degeneration 
Wilton (an In Vivo study)
Cork
Metabolism and Endocrinology Committee
Grant Holder Institution Project
Dr Malcolm Kell/ Department of Surgery The use of local immune stimulants 
Professor Redmond Cork University Hospital to enhance impaired wound healing
Wilton
Cork
Dr Leonie Young Department of Endocrinology ACTH regulation of adrenocortical 
St Vincent’s University Hospital steroidgeneis
Elm Park
Dublin 4
Professor Finian Martin Department of Pharmacology Mammary gland involution 
University College Dublin triggered post-translational
Biotechnology Centre modification of transcriptional
Belfield activators
Dublin 4
Dr John Nolan Department of Investigative Early onset Type 2 diabetes:
Endocrinology metabolic and molecular
St James’s Hospital studies to define early markers of 
James’s Street insulin resistance and beta cell 
Dublin 8 dysfunction
Microbiology and Virology Committee
Grant Holder Institution Project
Dr Derek Sullivan/ Department of Oral Surgery, Oral Responses of Candida Albicans
Professor Coleman Medicine & Oral Pathology Candida Dubliniensis to
School of Dental Science environmental stress
Trinity College
Dublin 2
Professor Timothy Foster Microbiology Department The role of clumping factor
Moyne Institute of Preventative inhibition of phagocytosis 
Medicine of Staphylococcus Aureus and in 
Trinity College bacterial virulence
Dublin 2
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Dr James McInerney Department of Biology Detection of adaptive evolution
National University of Ireland in microbial and viral pathogenicity 
Maynooth associated genes
Co Kildare
Dr Dermot Walls School of Biotechnology Regulation of the anit-apoptotic 
Dublin City University gene bfi-1 by Epstein-Barr virus
Glasnevin
Dublin 9
Dr Cliona O’Farelly/ Education & Research Centre Hepatitis C viral load qualification 
Dr Deignan St Vincent’s University Hospital in lymphocyte sub-populations and
Elm Park correlation with CD81 expression:
Dublin 4 Implications for treatment and 
prognosis
Dr Billy Bourke Children’s Research Centre Host-cell interactions of ‘human’
Our Lady’s Hospital for Sick Children and ‘bovine’ genotypes of 
Crumlin Cryptosporidium Parvum
Dublin 12
Dr Wim Meijer Department of Industrial Microbiology Life in the lion’s den:  effects
Conway Institute of Biomolecular of the intracellular pathogen
& Biomedical Research Rhodococcus Equi on macrophage 
University College Dublin gene expression
Belfield
Dublin 4
Molecular and Cell Biology Committee
Grant Holder Institution Project
Dr Thomas Moore Department of Biochemistry The cellular function of the JERKY
University College Cork protein in relation to human 
Wilton epilepsy
Cork
Dr Veronica Campbell Department of Physiology A study of the mechanisms 
Trinity College underlying B-amyloid-induced
Dublin 2 neurodegeneration
Dr Catherine Godson Department of Medicine & Therapeutics Lipoxin, Leukotriene and PDGF
The Conway Institute of Biomolecular receptor cross-talk in renal 
& Biomedical Research mesangial cells
University College Dublin
Belfield
Dublin 4
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Dr Judith Harmey Department of Surgery Vascular endothelial growth factor
RCSI/Beaumont Hospital (VEGF) – induced BCI-2
Beaumont Road expression
Dublin 9
Neurosciences and Mental Health Committee
Grant Holder Institution Project
Dr Kay Ohlendieck Department of Pharmacology Influence of motor innervation on
University College Dublin the oligomeric status of the 
Belfield nicotinic acetylcholine receptor
Dublin 4 and associated components at the
neuromuscular junction
Dr Aiden Corvin/Dr Gill Department of Psychiatry A quantitative-trait based 
Trinity Faculty of Health Sciences association study of schizophrenia
St James’s Hospital and related psychoses
James’s Street 
Dublin 8
Dr Adrienne O’Gorman Department of Biochemistry The effect of hypoxia on neuronal 
University College Galway differentiation and gene expression
Galway
Dr Caroline Herron Department of Human Anatomy Molecular basis for B-amyloid
& Physiology mediated neurotoxicity on 
University College Dublin synaptic transmission and long-
Earlsfort Terrace term potentiation
Dublin 2
Professor Marina Lynch Department of Physiology Analysis of the role of the 
Trinity College neutrophin BDNF in expression
Dublin 2 of long-term potentiation in the 
rat dentate gyrus
Dr Michael Rowan Department of Pharmacology Synaptic plasticity and B-amyloid
& Therapeutics
Trinity College
Dublin 2
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Oncology and Haematology Committee 
Grant Holder Institution Project
Dr Martin Clynes National Cell & Tissue Culture Does Survivin affect resistance to 
Centre chemotherapy and radiation in 
Dublin City University human cancer cells?
Glasnevin
Dublin 9
Professor Seamus Martin Department of Genetics Disecting the role of Survivin in
Trinity College apoptosis and tumorigenesis
Dublin 2
Dr William Gallagher Department of Pharmacology Expression profile analysis using
Conway Institute of Biomolecular cDNA microassays towards a more
& Biomedical Research global understanding of tumour cell
University College Dublin growth invasion and drug 
Belfield resistance
Dublin 4
Dr Carmel Daly/Dr Clynes National Cell & Tissue Culture Investigation of the possibility that
Centre ribolyme cleavage of bcl-XL 
Dublin City University mRNA may produce a novel
Glasnevin proapoptotic protein in human 
Dublin 9 cancer cells
Dr Ursula Bond Moyne Institute for Preventative Immune-responsiveness of tumour-
Medicine specific antigens from breast cancer 
Microbiology Department cells
Trinity College
Dublin 2
Other
Grant Holder Institution Project
Dr Thomas Clive Lee Department of Anatomy Microdamage and bone quality –
Royal College of Surgeons in Ireland development of a non-invasive, 
123 St Stephen’s Green repeatable technique for measuring
Dublin 2 microdamage accumulation in bone
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Public Health and General Practice Committee
Grant Holder Institution Project
Dr Patrick Brennan School of Diagnostic Imaging Reference dose levels and the 
University College Dublin standardization of image quality
Herbert Avenue for paediatric diagnostic X-ray
Dublin 4 examinations
Professor Ivan Perry Department of Epidemiology & Public Socio-economic status, 
Health psycho-social factors and
University College Cork coronary heart disease: A 
Wilton community-based case control 
Cork study
Professor Colin Bradley Department of General Practice Anti-depressant adherence study
University College Cork
Wilton
Cork
Reproductive Medicine Committee
Grant Holder Institution Project
Professor Colm O’Herlihy/ Department of Obstetrics & Prospective investigation of the
Mr O’Connell Gynaecology mechanisms and management of
National Maternity Hospital faecal incontinence of obstetric
Holles Street origin
Dublin 2
Dr Bridgette Byrne/ Department of Obstetrics & Foetal DNA – a genetic marker for
Professor O’Herlihy Gynaecology, UCD pre-eclampsia?
Coombe Women’s Hospital
Dublin 8
Dr Geraldine Gaffney/ Department of Obstetrics & Genetic variation in the factor V 
Ms Maher Gynaecology gene associated with activated 
University College Hospital protein C resistance in pregnancy
Galway
Respiratory Diseases Committee
Grant Holder Institution Project
Dr Philip Nolan/ Department of Human Anatomy The influence of hypoxaemia on 
Dr McNicholas & Physiology upper airway reflexes
Conway Institute of Biomolecular
& Biomedical Research
University College Dublin
Dublin 4
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Dr Deirdre Walsh/ Respiratory Research Elucidation of the inflammatory 
Professor P McLoughlin Department of Medicine mechanisms associated with cystic
RCSI/Clinical Investigations Unit fibrosis airway epithelial cells -
Beaumont Hospital investigation of gene therapy 
Dublin 9 strategies to overcome this 
response
Professor P McLoughlin Department of Human Anatomy The role of RHo A in the control
& Physiology of vascular resistance in normal 
University College Dublin and chronically hypoxic lungs
Earlsfort Terrace
Dublin 2
Joint HRB/Arthritis Foundation Project Grants 
Grant Holder Institution Project
Professor Fergal O’Gara et al. BIOMERIT Research Centre The immunogenetics of cytokine
Microbiology Department production in RA patients
University College Cork
Cork
Dr Evelyn Murphy Department of Rheumatology Modulation of the transcription 
St Vincent’s University Hospital factor NURR1as a component of 
Elm Park the inflammatory process in human
Dublin 4 arthritis
Dr Patrick Costello/ Department of Rheumatology T cell receptor repertoire analysis 
Dr Fitzgerald St Vincent’s University Hospital in seronegative arthritis: evidence
Elm Park for persistence of oligoclonal T
Dublin 4 cells in remission tissue
Professor Luke O’Neill Department of Biochemistry Targeting novel components in the 
Trinity College interleukin-1 system in the effort to 
Dublin 2 develop novel therapies for 
rheumatoid arthritis
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2. Health Services Research Fellowships
Fellow Project
Ms Laura Frost Barriers to breast feeding
University College Cork
Wilton 
Cork
Ms Mary Smith Organ donation: Current situation and future prospects 
Health Services Research Centre in Ireland
Royal College of Surgeons in Ireland
Dublin 2
Ms Patricia White An investigation into the care of people with type II
School of Nursing and Midwifery diabetes mellitus in Ireland
Trinity Faculty of Health Sciences
St James’s Hospital
James’s Street
Dublin 8
3. Clinical Research Training Fellowships
Fellow Project
Dr Brian Sweeney The role of polyunsaturated fatty acids in modulating
Children’s Research Centre monocyte apoptosis
Our Lady’s Hospital for Sick Children
Crumlin
Dublin 12
Dr Anne Gribbin The use of Intensity Modulated Radiotherapy techniques 
St Luke’s Institute for Clinical Research to minimise normal tissue toxicity and maximise tumour
Highfield Road control in patients with cancer of the head or neck over
Rathgar a period of two years
Dublin 6
Dr Daniel Costello Use of a cell line expressing the neurotrophin GDF-5 to 
Department of Anatomy enhance the survival of transplanted dopaminergic 
University College Cork neurones in a rat model of Parkinson’s Disease
Wilton
Cork
Dr Christopher Steele The role of cyclo-oxygenase and vascular endothelial
Beaumont Hospital growth factor over a period of two years
Beaumont Road
Dublin 9
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Dr Michael Alexander Clinical and genetic features of amyotrophic lateral
Department of Neurology sclerosis in Ireland
Beaumont Hospital
Beaumont Road
Dublin 9
Dr Louise Connolly Suicidal behaviour in Irish children and adolescents
Department of Child and Family
Psychiatry
90 O’Connell Street
Limerick
Dr John Cullen Upper airway sensory receptors as a defence against
Resp. Sleep Laboratory obstructive apnoea in humans
St Vincent’s University Hospital
Elm Park
Dublin 4
Dr Ronan Cahill Involvement of mass cell-associated vascular endothelial 
Department of Surgery growth factor (VEGF) in the pathogenesis of post-operative
Cork University Hospital peritoneal adhesion
Wilton
Cork
4. Post-Doctoral Research Fellowships
Fellow Project
Dr Aine Kelly A study of signalling pathways stimulated by NGF in the 
Department of Physiology dentate gyrus of the rat: analysis of age-related changes in
Trinity College long-term potentiation
Dublin 2
Dr Christine E Loscher Neuro-immunological basis of vaccine reactogenicity
Infection and Immunity Group
Department of Biology
National University of Ireland
Maynooth 
Co Kildare
Dr Keith J Murphy Identification of cortical site involved in reciprocal
Department of Pharmacology interactions with the medial temporal lobe vital to
University College Dublin the eventual commitment of information to long-
Belfield term memory
Dublin 4
64
Dr Trudee Fair Molecular cell biology of acquisition of embryo 
Department of Animal Science & Production developmental competence
Lyons Research Farm UCD
Newcastle 
Co Dublin
5. Clinical Research Fellowships in Nursing and Midwifery
Fellow Project
Ms Sile Creedon Nurses hand decontamination practices: compliance with
Department of Nursing Studies recommended guidelines
University College Cork
Western Road
Cork
Ms Ellen Savage A study on the dietary management of children with cystic
Department of Nursing Studies fibrosis: parents’ and children’s perspectives
University College Cork
Western Road
Cork
Mr Kevin Connaire An exploration of clinical expertise in palliative nursing
School of Nursing and Midwifery
University College Dublin
Belfield
Dublin 4
6. Cancer Epidemiology Fellowships
Fellow Project
Dr Paul Walsh Cancer Consortium Fellowship
National Cancer Registry
Elm Court
Boreenmanna Road
Cork
Dr Peter McCarron Cancer Consortium Fellowship
Northern Ireland Cancer Registry
Department of Epidemiology &
Public Health
Queen’s University
Belfast
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7. North–South Research Projects
Southern Partner(s) Northern Partner(s) Project
Professor John Dalton/Dr Doyle Dr Aaron Maule/Professor Halton The role of peptidases in the
School of Biotechnology School of Biology & Biochemistry regulation of neurotransmission
Dublin City University Queen’s University signalling in the parasitic
Glasnevin Belfast helminths Fasciola Hepatica
Dublin 9 and Schistosoma Mansoni
Dr Mark Lawler/Professor Hollywood Dr Tracy Robson Selective activation of transgenes
Department of Haematology School of Biomedical Sciences to enhance radiotherapy in
St James’s Hospital University of Ulster at Jordanstown prostate cancer
James’s Street Newtownabbey
Dublin 8 Co Antrim
Professor Timothy Foster Professor Mark Pallen Exploiting the genome sequences
Department of Microbiology Department of Microbiology of staphylococcus aureus
Trinity College Dublin & Immunobiology
Dublin 2 Queen’s University
Belfast
Dr Clare O’Connor Dr J Stuart Elborn Evaluation of the contribution
Department of Medicine and Regional Adult Cystic Fibrosis of a polymorphism in the
Therapeutics Unit a1-proteinase inhibitor gene to
University College Dublin Belfast City Hospital pulmonary disease in Cystic
Dublin 4 Belfast Fibrosis
8. Interdisciplinary Research Project
Project
Dr Martin Clynes Dr Anita Maguire Design, synthesis and biological
National Cell & Tissue Culture Centre Department of Chemistry evaluation of novel MRP
Dublin City University University College Cork inhibitors to enhance the
Glasnevin Wilton activity of anti-cancer drugs
Dublin 9 Cork
9. Research Project Grants Co-Funded in Health Services Research
Grant Holder Project Co-Funder
Dr Susan Smith The North Dublin Diabetes Shared Coombe Health Care Centre
University College Dublin Care (DiSC) project: A randomised Dublin 8
Coombe Health Care Centre controlled trial and economic 
Dublin 8 evaluation
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Professor Cecily Kelleher Support for older people and their carers Western Health Board
Department of Health Promotion
Clinical Science Institute
NUI Galway
Dr Suzanne Cahill Architecture and Dementia: An Alzheimer Society of Ireland
Dementia Service Information exploratory study of nursing homes and
& Development Centre their spatial environment
St James’s Hospital
Dublin 8
Ms Fiona Healy Pathways for the elderly through Western Health Board
Western Health Board Western Health Board Hospitals
Mayo General Hospital
Castlebar
Co Mayo
Ms Marie Lawless An investigation into the health status
The Merchant’s Quay Project of female drug users
4 Merchant’s Quay
Dublin 8
Dr Finnuala McAuliffe Prospective study of short-term Coombe Women’s Hospital
Coombe Women’s Hospital morbidity anticipated of elective Dublin 8
Dublin 8 caesarean section versus vaginal  
delivery
Dr Eilis Hennessy A telephone interview protocol for Department of Psychology
Department of Psychology the Hospital Evaluation Instrument University College Dublin
University College Dublin for Children
Belfield
Dublin 4
10. Equipment Grants
Applicant Co-Applicant Equipment
Professor James Docherty Dr Aiden McCormick Blood pressure recording 
Department of Physiology Liver Unit equipment
Royal College of Surgeons St Vincent’s University Hospital
in Ireland Elm Park
Dublin 2 Dublin 4
Dr Carmel Hensy Dr Kay Ohlendieck Beckmann Coulter optima max
Department of Pharmacology Department of Pharmacology tabletop ultra-centrifuge
University College Dublin University College Dublin
Belfield Belfield
Dublin 4 Dublin 4
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Applicant Co-Applicant Equipment
Dr Lesley Mynett-Johnson Professor Peter Humphries DNA separation/purification
Department of Genetics Department of Genetics equipment
Trinity College Trinity College 
Dublin 2 Dublin 2
Professor Michael Ryan Dr Carmel Hensy Wallace 1420 VICTOR-
Department of Pharmacology Department of Pharmacology multilable counter 
University College Dublin University College Dublin
Belfield Belfield
Dublin 4 Dublin 4
Dr Geraldine Butler Dr Philip Newsholme Class 2 biosafety hood with
Department of Biochemistry Department of Biochemistry double HEPA filter system
University College Dublin University College Dublin and accessories
Belfield Belfield
Dublin 4 Dublin 4
Dr Desiree Bennett Dr Mary Cafferkey ABI PRISM 7700 sequence
Meningococcal Ref. Laboratory Meningococcal Ref. Laboratory detection system
The Children’s Hospital The Children’s Hospital
Temple Street Temple Street 
Dublin 1 Dublin 1
Professor Peter Humphries Dr G Jane Farrar RETI-port Gamma plus 
Ocular Genetics Unit Ocular Genetics Unit electro-physiology
Trinity College Trinity College
Dublin 2 Dublin 2
Dr Philip Newsholme Professor Paul Malthouse Cell culture equipment 
Department of Biochemistry Department of Biochemistry
University College Dublin University College Dublin
Belfield Belfield
Dublin 4 Dublin 4
Professor Gerald O’Sullivan Professor Fergus Shanahan ECM2001 – Electro cell
Cork Cancer Research Centre Department of Medicine manipulator and 
Mercy Hospital Cork University Hospital accessories
Grenville Place Wilton
Cork Cork
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Applicant Co-Applicant Equipment
Professor Andrew Green Dr David Barton Transgenomic WAVE nucleic
Department of Medical Genetics Deptartment of Medical Genetics acid fragment analyser
UCD/ National Centre for Medical UCD/ National Centre for Medical 
Genetics Genetics
Our Lady’s Hospital for Sick Children Our Lady’s Hospital for Sick Children
Crumlin Crumlin
Dublin 12 Dublin 12
Professor Marina Lynch Dr Veronica Campbell Spectramax Dual Scanner
Department of Physiology Department of Physiology Microplate spectro-flurometer
Trinity College Trinity College Electrophoresis immunoblotting
Dublin 2 Dublin 2 station
Professor Christopher Bell Professor Barry Roberts Openlab high performance 
Department of Physiology Department of Zoology confocal imaging system
Trinity College Trinity College
Dublin 2 Dublin 2
Dr Michael Carty Dr Maria Tuohy BMG FLURO star Galaxy
Department of Biochemistry Department of Biochemistry multi-well plate reader
National University of Ireland National University of Ireland
Galway Galway
Professor David Coleman Professor Conor T Keane Optical real-time PCR thermal
Microbiology Research Laboratory Department of Clinical Microbiology cycler
School of Dental Science St James’s Hospital 
Trinity College James’s Street
Dublin 2 Dublin 8
Professor Michael Gill Dr Dan Bradley Biomek 2000 and accessories
Department of Psychiatry Department of Genetics
St James’s Hospital Trinity College
James’s Street Dublin 2
Dublin 8
Dr Mark Rogers Chemiluminescence imaging
Department of Zoology system and associated computer
University College Dublin and software
Belfield
Dublin 4
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Applicant Co-Applicant Equipment
Dr Caroline Herron Patch clamp rig
Department of Human Anatomy
University College Dublin
Earlsfort Terrace
Dublin 2
Dr Amanda McCann Professor Peter Dervan Light Cycler real-time PCR
Pathology Department Pathology Department system
University College Dublin UCD & Mater Hospital
Belfield Eccles Street
Dublin 2 Dublin 7
Professor Clive Williams Professor Luke O’Neill Beckman Coulter BIOMEK 2000
Biochemistry Department Biotechnology Institute automated pipetting station
Trinity College Trinity College 
Dublin 2 Dublin 2
Professor Paul McLoughlin Professor M Fitzgerald Chemiluminescent nitric oxide
Department of Physiology Medical Professorial Unit analyzer - Sievers NOA-280
University College Dublin St Vincent’s University Hospital
Earlsfort Terrace Elm Park
Dublin 2 Dublin 4
Dr Cliona O’Farrelly Dr Teresa Maguire Labsystems Flouroskan Ascent 
Education & Research Centre Department of Surgery FL: Combined flourometric/
St Vincent’s University Hospital St Vincent’s University Hospital luminometric 
Elm Park Elm Park
Dublin 4 Dublin 4
Dr Caroline Sharkey Professor Kevin Nolan Silicon Graphics O2 workstation
Department of Clinical Pharmacology Department of Chemistry
Royal College of Surgeons Royal College of Surgeons
in Ireland in Ireland
Dublin 2 Dublin 2
Dr Denis O’Mahony Professor George Shorten Nitric oxide chemiluminescence
Department of Anaesthesia Cork University Hospital analyser
Cork University Hospital Wilton
Wilton Cork
Cork
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Applicant Co-Applicant Equipment
Professor Hugh Brady Professor Paul McLoughlin Coy Laboratory Products hypoxia
Department of Medicine Department of Physiology dual chamber system
Mater Hospital University College Dublin
Eccles Street Earlsfort Terrace
Dublin 7 Dublin 2
Dr Thorfinnur Gunnlaugsson Professor John M Kelly HPLC unit
Department of Chemistry Department of Chemistry
Trinity College Trinity College
Dublin 2 Dublin 2
Dr Walter McNicholas Dr Philip Nolan Polysomnograph digital sleep
St Vincent’s University Hospital Department of  Anatomy and cardio-respiratory
Elm Park University College Dublin recording system
Dublin 4 Earlsfort Terrace
Dublin 2
Professor David Taylor Dr Clive Lee PE biosystem 7700 sequence 
Department of Mechanical Department of Anatomy detection system
Engineering Royal College of Surgeons 
Trinity College in Ireland
Dublin 2 Dublin 2
Professor Finian Martin Professor Hugh Brady GenePix 4000A microarry
Department of Pharmacology Dr William Gallagher scanner 
University College Dublin Dr Geraldine Butler
Belfield Dr Wim Meijer
Dublin 4 University College Dublin
Belfield
Dublin 4
Professor Thomas Cotter Dr Cora O’Neill Cryostat HM560 cryo-star and
Department of Biochemistry Department of Biochemistry vacutome
University College Cork University College Cork
Wilton Wilton
Cork Cork
Dr Anthony Staines Professor Leslie Daly IBM Netfinity rack-mounted
Department of Public Health Department of Public Health server system and software
Medicine & Epidemiology Medicine & Epidemiology
University College Dublin University College Dublin
Earlsfort Terrace Earlsfort Terrace
Dublin 2 Dublin 2
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Applicant Co-Applicant Equipment
Dr John Kelly Dr Thomas Cotter ESA Model 5200A Coulochem
Department of Pharmacology Department of Pharmacology II detector: Dual protentiostat
National University of Ireland National University of Ireland ECD
Galway Galway
Dr Stuart Bund Dr James Jones Vascular imaging system
Department of Human Anatomy Department of Human Anatomy
& Physiology & Physiology
University College Dublin University College Dublin
Earlsfort Terrace Earlsfort Terrace
Dublin 2 Dublin 2
Professor Michael Rowan Professor Roger Anwyl Axona expandable 16-channel
Department of Pharmacology Department of Physiology recording system 
Trinity College Trinity College
Dublin 2 Dublin 2
Dr John Lowery Professor Kingston Mills Computerised biomedical electro-
Bioelectranalysis Laboratory Department of Biology chemical workstation
National University of Ireland National University of Ireland
Maynooth Maynooth
Co Kildare Co Kildare
Professor Tommie McCarthy Dr Cora O’Neill Ratio fluorescence imaging
Department of Biochemistry Department of Biochemistry system: Inverted microscope
University College Cork University College Cork with epifluoresence
Wilton Wilton
Cork Cork
Dr Kathleen Quane Professor Nollaig Parfrey Applied biosystems ABI PRISM
Department of Medicine Department of Pathology 310 genetic analyser 
Cork University Hospital Cork University Hospital
Cork Cork
Dr Kenneth Wolfe Mr Karsten Hokamp Expansion of existing Beowulf
Department of Genetics Department of Genetics Linux PC cluster 
Trinity College Trinity College
Dublin 2 Dublin 2
Dr Stephen Smith Professor Charles Dorman A suite of equipment for 
Department of Microbiology Department of Microbiology proteomic analyses
Trinity College Trinity College 
Dublin 2 Dublin 2
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Applicant Co-Applicant Equipment
Dr Marie Reilly Professor Ivan Perry Formic intelligent data capture
Department of Epidemiology & Department of Epidemiology & system: Central data server
Public Health Public Health plus three networked PCs
University College Cork University College Cork
Cork Cork
Dr Stephen Mayhew Dr Paul Malthouse Stopped-flow spectrophotometer/
Department of Biochemistry Department of Biochemistry fluorimeter system and
University College Dublin University College Dublin accessories
Belfield Belfield
Dublin 4 Dublin 4
Professor Keith Tipton Dr Gavin Davey Hewlett Packard HPLC:
Department of Biochemistry Department of Biochemistry Hewlett Packard UVVis 
Trinity College Trinity College system
Dublin 2 Dublin 2
Dr Paul Cahill Dr Brian McNamara Flexercell tension plus Flexflow 
School of Biotechnology Research Centre for Design (TM) shear stress system
Dublin City University & Manufacture
Glasnevin Dublin City University
Dublin 9 Glasnevin
Dublin 9
Professor John Bannigan Dr Raj Ettarh Leica CM 3050 Cryostat Rua
Department of Human Anatomy Department of Human Anatomy ultra low temperature freezer
& Physiology & Physiology model 540LV
University College Dublin University College Dublin
Earlsfort Terrace Earlsfort Terrace
Dublin 2 Dublin 2
Professor William Hall Contribution to CompuCyte
Department of Medical Microbiology laser scanning cytometer
University College Dublin (CLSC)
Belfield
Dublin 2
Dr Aideen Long Professor Clive Lee Image analysis system
Department of Biochemistry Department of Anatomy
Royal College of Surgeons Royal College of Surgeons
in Ireland in Ireland
Dublin 2 Dublin 2
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Applicant Co-Applicant Equipment
Dr Catherine Godson Professor Finian Martin Eppendorf micro-manipulator 
Department of Medicine & Biotechnology Centre and femtojet system including
Therapeutics University College Dublin microscope adapter
Mater Hospital Belfield
Dublin 7 Dublin 4
Dr William Gallagher Professor Finian Martin High-throughput PCR and liquid
Department of Pharmacology Department of Pharmacology handling system
University College Dublin University College Dublin
Belfield Belfield
Dublin 4 Dublin 4
Dr Cliona O’Farrelly Dr John Hegarty Immunofluorescent microscope:
Education & Research Centre Department of Hepatology Digital imaging system
St Vincent’s University Hospital St Vincent’s University Hospital
Elm Park Elm Park
Dublin 4 Dublin 4
Dr Joe O’Connell Mr Kenneth Nally Luminoskan ascent
Department of Medicine Department of Medicine
Clinical Science Building Clinical Science Building
Cork University Hospital Cork University Hospital
Wilton Wilton
Cork Cork
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